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This article estimates the socioeconomic costs of drug 
trafficking and consumption in Chile in 2006 —including 
the costs of prevention and health care, productivity 
losses and law enforcement— in order to allocate a 
monetary value to the negative externalities caused by 
illegal drugs in Chile.
A sound indicator of the socioeconomic costs of 
drug use and trafficking is needed in order to properly 
substantiate and justify public decisions and actions 
aimed at reducing the impacts of drugs. Single and 
others (2003) specify four purposes for this type of study:
(i) economic estimates help argue for prioritizing drugs 
policies on the public agenda; 
(ii) high-quality estimates provide a standard against 
which intervention needs can be weighed. Without 
such a standard, there will be a tendency for advocates 
for each social problem to overbid;
(iii) cost estimates help to target priority areas for 
action and identify failings in national reporting 
systems, and turn a spotlight on specific needs for 
improvement in national statistical systems; and 
(iv) the development of improved estimates provides 
baseline measures to determine the efficacy of drug 
policies and programmes.
A. Background
Developing a good indicator of the socioeconomic costs 
of illicit drug consumption has become a priority and a 
challenge in the past decade, especially in developing 
countries with high consumption rates (Pacula and 
others, 2009). However, few countries have managed 
to develop quality estimates and the methodologies 
used vary widely. Studies conducted in the United 
States (Office of National Drug Control Policy, 2004), 
Canada (Rehm and others, 2006) and Australia (Collins 
and Lapsley, 2008) are probably the most advanced in 
the field, although estimates of a high standard have 
also been conducted in France (Kopp and Philippe, 
2006), Spain (García-Altés, Ollé and Colom, 2002) 
and England and Wales (Godfrey and others, 2002). In 
Latin America, the Inter-American Drug Abuse Control 
Commission (cicad) of the Organization of American 
States (oas) has spearheaded the “Program to Estimate 
the Human, Social and Economic Costs of Drugs in the 
Americas”, aiming to promote this kind of research in 
the region. This has yielded cost estimates for Argentina, 
Barbados, Chile, Costa Rica, El Salvador, Mexico, Peru 
and Uruguay. The findings of these studies are highly 
uneven, however, owing to over-use of secondary 
sources, failure to distinguish between costs related 
to alcohol and those related to illicit drugs —grouped 
in the category “psychoactive substances”— and the 
lack of proper estimates of indirect costs. Not all the 
studies have these problems to the same degree, but 
the estimates produced are not of the highest standard. 
The failure to distinguish between legal and illegal 
substances is a basic problem these studies share and 
one which —as we will argue— means that they fall 
short of international studies.
B. what is a study of the socioeconomic costs 
of illicit drug use?
Studies of the socioeconomic costs of trafficking and 
use of illicit drugs are based on a “cost-of-illness” (coi) 
methodology, which compares a real scenario in which 
specific disease (in this case, trafficking and consumption 
of drugs) and its consequences exist, with a counterfactual 
scenario in which the disease does not exist (Kopp, 2001). 
This difference is quantified in monetary terms. What 
is being estimated is thus the magnitude of the costs to 
the country of illicit drug consumption, which would 
not exist in the absence of the “illness”.
Underlying this approach is the idea of opportunity 
cost, i.e. the cost incurred by investing resources in a 
particular activity (or an illness, in the coi approach), 
which could have been used for other available activities 
(Rehm and others, 2006). A coi study, then, quantifies the 
total reduction in the production of goods and services 
which can be attributed to the development of an illness 
(Kopp, 2001, page 26).
A coi estimate should not be confused with: 
(i) an avoidable cost study, (ii) a budgetary impact 
study, or (iii) a cost-benefit analysis. In the first place, 
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not attempt to quantify the economic resources which 
could “really” be saved through effective programmes 
and public policy. Whereas an avoidable cost study 
attempts to calculate the difference between the actual 
situation and a hypothetical situation that assumes a 
feasible success rate for a given policy, a coi approach 
contrasts the actual situation with one in which illicit 
drug consumption does not exist now and never has 
(Segel, 2006). Second, coi calculations measure the 
impacts of the illness not on the public budget, but on 
society as a whole, including items which transcend 
related public spending. Lastly, unlike a cost-benefit 
analysis, coi estimations do not quantify the possible 
benefits associated with drug consumption. Whereas a 
cost-benefit analysis asks what would happen if the costs 
associated with a particular behaviour were to cease 
from today, a coi estimation compares the reality with a 
counterfactual scenario in which consumption had never 
started (Single and others, 2003, pp. 21 and 22). Even 
if a particular behaviour, like drug consumption, were 
to stop instantly, the consequences of past consumption 
would remain: they constitute “unavoidable” costs and 
are thus excluded from cost-benefit analysis (Single 
and others, 2003, p. 22). Conversely, coi studies can 
contribute to cost-benefit analysis.
C. Limitations
Estimating the costs of illicit drug consumption, however 
useful, has many limitations and falls far short of capturing 
the true magnitude of the problem. The estimation 
results and methods show a quantification which is 
apparently precise but should be treated with caution. 
First, the accuracy of cost studies depends on information 
which even the developed countries are not producing 
comprehensively. Hence the frequent use of secondary 
data and proxy approaches to the problem, which make 
the findings somewhat uncertain even when they operate 
on reasonable, duly substantiated assumptions.
A second limitation is the lack of systemic studies 
on the indirect impacts of drug consumption on other 
cost-generating behaviours or diseases. In Chile there 
is an estimation of etiologic (or attributable) fractions1 
for drug-related crime (Valenzuela and Larroulet, 
2010), and a very precarious estimation of disability-
1  An etiologic fraction is the proportion of cases in which an “illness” 
(involvement in crime, in this case) can be attributed to exposure to a 
given risk factor (consumption of drugs).
adjusted life years (dalys) where drugs are a risk factor 
in diseases other than addiction (School of Medicine, 
2008). However, no etiologic fraction has been estimated 
for health (for evaluating the cost of treating diseases 
attributable partially to drug consumption) or for road 
traffic accidents.
Both points signal a major “external” limitation: 
despite our best efforts to generate a unified methodology 
for estimating coi for drug consumption —such as 
the notable work of Single and his colleagues at the 
Canadian Centre on Substance Abuse between 1994 
and 2001— the research must ultimately settle for the 
information available in each country. The findings thus 
have differences that preclude comparisons (Pacula and 
others, 2009).
However, a methodology needs to be properly 
defined if it is to be used to conduct comparisons over 
time, and to evaluate at least how total costs and each 
cost item have evolved. The present estimate represents 
considerable progress in this respect: it has yielded quite 
accurate results for productivity losses and the costs of law 
enforcement for drug offences and drug-related crime, two 
of the most substantial items in total costs. The greatest 
failing, however, lies in the drastic underestimation of 
the direct costs of drug consumption on health and in 
the lack of any estimate at all of indirect health-related 
costs. Accordingly, the costs estimated need to be scaled 
up; they should serve as a starting point or floor level for 
future research that could remedy this shortfall.
The estimates should ideally have been based on 
a more recent period, since changes in consumption 
patterns or in the institutional context —such as the 
enforcement of the juvenile criminal responsibility act 
or the restructuring of the drug prevention agency— 
could have altered the total cost of drug consumption 
in Chile in the past few years. However, the information 
for an older period is often more consolidated than for 
recent periods. Moreover, many prestigious international 
estimates operate with a similar lag, with the exception 
of England and Wales (Godfrey and others, 2002), 
where the lag is just two years, and Australia (Collins 
and Lapsley, 2008), where it is three.
Notwithstanding their acknowledged shortcomings, 
the findings represent significant progress with respect 
to previous estimates by the National Drug Control 
Council (conace) (2005) and Olavarría (2009). This 
article owes much to the Olavarría study. In addition, 
the estimates for enforcement are far from comparable 
to international estimates published so far.
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The definition of social costs used in coi studies differs 
from that commonly used in economics: whereas social 
costs usually refer to the total sum of costs associated 
with a particular behaviour or decision, here social cost 
refers to what is often termed an “externality”, a concept 
which implies the total exclusion of private costs. The 
resources consumers spend in the drug market are not 
considered social costs. Social costs refer instead to the 
socioeconomic burden imposed “on” society as a whole 
by individual agents whose consumption decisions do not 
factor in these consequences (Single and others, 2003, 
p. 14). Private costs do not generate State interventions 
because: (i) they originate in an entirely voluntary 
determination by the individuals making the decision 
to assume these costs (oas/cicad, 2006, p. 18), and 
are offset by individual benefits of at least the same 
magnitude; and (ii) insofar as they do not affect third 
parties, what is beneficial for the individual is assumed 
to be beneficial for society overall. In addition, drug 
spending by one agent represents income for another. 
This differentiation is one of the key aspects in which 
this article differs from Olavarría (2009).
The estimate involves no great conceptual difficulties. 
Structurally, it has three steps (Single and others, 2003, 
p. 14; oas/cicad, 2006):
— Identification of the adverse impacts of drug abuse.
— Documentation and quantification of the degree 
of causality between the abuse and the adverse 
impacts.
— Assignment of costs to the adverse impacts.
The first step is, in principle, fairly well agreed 
upon. The only aspect on which agreement is lacking is 
whether to include or exclude intangible costs, i.e. the 
emotional and physical burden (addiction, premature 
mortality, or fear of crime and victimization), which may 
be borne by drug users themselves or by people around 
them (Pacula and others, 2009, p. 6). Although these 
costs could represent a large share of the total burden of 
drug consumption,2 they are extremely hard to quantify 
(Kopp, 2001, p. 17; Segel, 2006, p. 4; Single and others, 
2003, p. 27) and measures are far from standardized. 
2   Collins and Lapsley (2008) estimate that the intangible costs of 
drug consumption represent 45% of total socioeconomic costs in 
Australia in 2004 and 2005.
For these reasons, only Collins and Lapsey (2008) have 
incorporated them properly into the study of illicit drug 
costs. The instruments for this sort of analysis are not 
available in Chile.
The second step is more controversial. Initially, it 
distinguishes between direct and indirect costs: direct costs 
are those in which 100% causality can be established a 
priori (e.g. the direct costs incurred by treating addiction); 
indirect costs are those where imputation is partial 
and requires duly substantiated etiologic fractions to 
quantify the impact of the consumption of each drug 
on cost-generating behaviours or situations. In Chile, 
rigorous etiologic fractions for indirect costs are available 
only for law enforcement, i.e. the percentage of crime 
committed as a result of the use and trafficking of illicit 
drugs, and not only under their influence. Estimates, 
albeit less precise, also exist for indirect costs of drug 
consumption under the item of productivity losses, 
arising either from imprisonment or loss of healthy life 
years (dalys). 
However, there are no etiologic fractions to quantify 
the impacts of drug consumption on diseases other 
than addiction, which would help to determine what 
consumption costs the health system through derived and 
partially attributable illnesses. The lack of estimates for 
this item is probably the greatest defect of the calculations 
presented here. This article also excludes the cost of 
damage to property resulting from road traffic accidents, 
since no studies exist on etiologic fractions in this area. 
Unlike Olavarría (2009),3 here we have preferred to 
maintain a conservative stance in the estimates. 
With regard to the third and last step, fairly high 
quality information was available for most of the items 
in this work, and duly substantiated estimates in cases 
where no direct data exist. The sources and allocation 
methods are set forth for each item. 
3  Olavarría’s procedure imputes to drugs the full cost generated by 
road traffic accidents where an illicit substance was detected. This 
is not adequately substantiated and overstates the measurement. As 
Longo and others (2000a and 2000b) show, the responsibility rate 
in road traffic accidents varies widely by type of drug and may even 
reflect an inverse correlation for drivers with low blood concentrations 
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Cost structure
The costs considered in the study were grouped into 
direct and indirect costs for four items: 
i. Prevention: includes campaigns, money provided for 
drug research and the entire budget of the National 
Drug Control Council (conace)4 not corresponding 
to these areas or to rehabilitation.
4  In February 2011 conace was refounded as the National Service for 
Drug and Alcohol Consumption Prevention and Rehabilitation (senda).
ii. Health: treatment in the public system for drug 
consumption. The private system and indirect costs 
are excluded owing to lack of information and of 
studies on etiologic fractions.
iii. Productivity losses: the opportunity costs of dalys 
attributable to mortality and morbidity resulting 
from drug addition, the drug-attributable risk of 
other diseases, and imprisonment for crimes directly 
and indirectly related to drugs.
iv. Enforcement: resources used to prosecute crime 
and infringements of the drugs law and crimes 












Productivity losses Imprisonment for offences against drugs 
law
Addiction-related mortality and morbidity
Imprisonment for partially attributable crimes
Mortality and morbidity partially attributable to drug 
consumption (where drugs are a risk factor)
Enforcement 
(Each subitem for adults and 
juveniles separately)
Offences against drugs law:
   Police system
   Judicial system
   Penal system / sename
   Other institutions
Enforcement costs for partially attributable crimes:
   Police system
   Judicial system
   Penal system / sename
Source: prepared by the author.
conace: National Drug Control Council.




As illustrated in tables 2 and 3, in 2006 drug consumption 
in Chile represented an economic burden of at least 
266.744 billion Chilean pesos (clp) at that year’s prices 
(or 318.681 billion pesos in today’s terms, at 30 April 
2011). This is equivalent to over US$ 503 million (in 
average nominal terms for 2006), and represented 0.45% 
of gdp that year, and a per capita cost of clp 16,233 or 
US$ 31 (see tables 2 and 3). 
The largest portion of these costs (47%) was 
expended on law enforcement in relation to crimes 
committed either against the drugs law or because of 
drugs (to obtain them, in the case of addicts; under 
their influence, where the individual would not have 
committed the crime otherwise; or in the drugs market). 
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The next largest cost is productivity losses, at 46% of 
the total. Together, these two items represent 93% of the 
total socioeconomic costs of drugs in Chile, although 
this proportion is over-estimated owing to the under-
estimation of health costs, which inflates the relative 
proportion of the other items. Prevention costs represent 
5% of the total, and public health costs, 2%. 
The study for 2003 (conace, 2005) found a very 
different cost distribution: in this case, too, the largest 
share was represented by enforcement —an even larger 
percentage than we find— and the second largest by 
productivity losses (23%). The conace study heavily 
over-estimated for enforcement, because crimes were 
imputed to drug consumption merely by possession 
(no etiologic fractions were used), and heavily under-
estimated for productivity losses owing to failings in 
the data sources used. This article corrects that failing 
by using a study by the School of Medicine (2008) on 
disease burden and attributable burden to arrive at a 
more accurate estimate of the economic burden of drug 
addiction and drug consumption. 
The third item, public health, represented 16% of 
total costs: the greater magnitude in this case reflects the 
fact that the estimates were conducted on the basis of 
secondary sources which yielded different results from 
the budgetary information on which the present work is 
based, as well as the inclusion of indirect costs on the 
basis of a study on drug consumption in emergency room 
patients “Estudio de consumo de drogas en consultantes 
de los servicios de urgencia” (conace/ciges, 2001). 
However, the drug-attributable fractions in that study 
were estimated as a percentage of total admissions for 
external causes in which the presence of drugs was 
detected by a urine test. Again, this means attributing 
to drug use the whole set of incidents in which they are 
detected; for example, drugs were treated as the sole 
cause in all accidents in which they were found to be 
present. As we have argued, this procedure is highly 
questionable: if drugs explain 100% of the accident, 
it is then impossible to explain accidents in which no 
drugs were detected. The lack of any study that provides 
reliable etiologic fractions is the reason why this estimate 
does not include indirect costs under the public health 
item, notwithstanding that this means leaving out a 
particularly significant item. 
Fourth and last, this article finds that prevention 
represents 11.6% of total costs, more than in the 
2006 study. This is explained by the smaller volume 
of total costs, since the absolute value of this item 
rose considerably (from US$ 13.2 million in 2003 to 
US$ 24.7 million in 2006). But, since the sources and 
methodologies used differ significantly, this comparison 
is merely illustrative and does not reflect actual changes.
TABLE 2
Estimated socioeconomic costs of drug consumption in Chile: 
total and by item, 2003 and 2006












Prevention 9 103 13 166 11.6 13 070 24 647 4.9
Public health 12 625 18 260 16.0 5 093  9 605 1.9
Productivity losses 18 187 26 305 23.1 122 293 230 620 45.9
Enforcement 38 852 56 193 49.3 126 288 238 154 47.3
Total 78 767 113 924 100 266 744  503 026 100
Nominal at 30 April 2011 101 503 220.4 100 318 681 692.0 100
Source: prepared by the author on the basis of data for 2003 from the National Drug Control Council (conace), Estudio de costos asociados 
al consumo y tráfico de SPA ilegales en Chile para el año 2003, Santiago, Chile, 2005. 
TABLE 3
Estimates of socioeconomic cost of drug 
consumption: overall results, 2003 and 2006
2003 2006
Cost of drug consumption in  
millions of pesos 78 767  266 744
Percentage of gdp 0.15 0.45
Per capita cost in pesos 4 948  16 233 
Per capita cost in dollars 7.2 30.6 
Source: prepared by the author on the basis of data for 2003 from 
the National Drug Control Council (conace), Estudio de costos 
asociados al consumo y tráfico de SPA ilegales en Chile para el 
año 2003, Santiago, Chile, 2005. 
gdp: gross domestic product.
93
ThE SoCIoEConomIC CoST of ILLICIT dRUG ConSUmPTIon In ChILE  •  mATíAS fERnándEz h.
C E P A L  R E V I E W  1 0 7  •  A U G U S T  2 0 1 2
B. Estimates of the socioeconomic costs of 
drug consumption by item
1. Prevention
As shown in table 4, in 2006 prevention costs amounted 
to clp 13.07 billion, funded mostly from the budget of the 
National Drug Control Council (conace). What is now 
the National Service for Drug and Alcohol Prevention 
and Rehabilitation (senda, formerly conace) finances 
most of the work of drug consumption prevention in 
Chile. Its priority activity “senda Previene” (formerly 
a conace programme entitled “Previene”) receives an 
additional autonomous contribution from the municipal 
government for local implementation. conace also 
makes transfers to regional and subregional governments 
and —for research purposes— to the United Nations 
Development Programme (undp), the National Children’s 
Service (sename) and other community agencies, such as 
foundations, churches and private non-profit corporations. 
The largest cost —which is, however, indirectly linked 
to prevention— is “other conace costs”, which is the 
sum of all conace costs other than those listed above 
and of transfers for rehabilitation, including under public 
health costs. These other costs correspond mainly to 
the Council’s national level administrative costs. They 
are included under this item because the Council’s 
ultimate aim is prevention and in the absence of drug 
consumption (the counterfactual scenario), it would not 
exist at all. Lastly, the investigative branch of the Chilean 
police force, Policía de Investigaciones de Chile (pdi), 
makes a small contribution through its Department of 
Antinarcotics Education and Public Safety for workshops 
on preventing drug consumption. 
2. Public health
Public health usually represents a high portion of total 
costs in international coi studies. By contrast, here the 
costs to the public health system of the use and abuse 
of illicit drugs are grossly underestimated. Not only 
are indirect costs not counted —since there is no study 
on drug-attributable fractions for related diseases in 
Chile— but the direct costs are underestimated as well 
because of the lack of information on private health care 
and treatment for addiction. 
Olavarría (2009) attempted to estimate private health 
costs attributable to drugs. He calculated the total number 
of treatments conducted in Chile using the expanded 
database of the conace study of the general population 
for 2006, assigning each treatment the corresponding 
public system value and subtracting from that sum the 
known total cost of treatments paid for out of public 
funds. It is thus assumed that the cost of private health 
treatment is given by subtracting known costs from the 
total costs estimated using the survey. Theoretically this 
exercise is reasonable, and since it does not separate drug 
and alcohol costs, the estimate is apparently plausible. 
However, when, in this procedure, the drug-related 
costs are separated from alcohol-related costs, the results 
become so nonsensical that negative costs are found for 
certain types of treatment; for example, there are cases 
TABLE 4
Prevention costs, 2006
(Millions of pesos in nominal terms)
Prevention - conace conace en su comuna: “Previene” 2 681
conace transfers to regional governments 2 049
conace transfers to provincial governments 96
conace transfers to community organizations 702
conace transfers to undp 21
conace – sename agreement 149
conace transfers to other agencies 710
Other conace costs (not including rehabilitation) 5 965
Prevention – other institutions pdi workshops 14
Municipalities (independent contributions to Previene scheme) 683
Total 13 070
Source: prepared by the author on the basis of data for 2003 from the National Drug Control Council (conace), Estudio de costos asociados 
al consumo y tráfico de SPA ilegales en Chile para el año 2003, Santiago, Chile, 2005
conace: National Drug Control Council.
sename: National Children’s Service. 
undp: United Nations Development Programme. 
pdi: Chilean police force investigative branch.
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in which the public system (known number) registers 
more treatments than the total estimated number arising 
from the survey (which should correspond, in Olavarría’s 
strategy, to the sum of public and private treatments). 
This absurd finding highlights the risk of generalizing 
by extrapolating a very small number of cases to the 
national level, and provides conclusive grounds for 
excluding this item for lack of information.
In public health, Chile does not have direct sources 
of information on the costs of primary and hospital care 
attributable exclusively to illicit drugs; in the health 
system the two types of treatment —for drugs and 
alcohol— come under a single budget item. The costs 
linked to each of these two problems can, however, be 
estimated relatively accurately from the proportion of 
hospital bed occupancy for each, according to records 
of the Health Data and Statistics Department (deis) for 
2006. Tables 5 and 6 show the data used to perform 
this calculation.
Although alcohol-related hospital stays represent 
75.5% of total stays in relation to both substances, the 
duration of drug-attributable stays is considerably longer, 
with an average of 19.4 days per patient, far more than 
the average 9.3 days stay in alcohol-attributable cases. 
Thus, the public system covered 69,683 days of hospital 
bed occupancy for alcohol and 47,441 for illicit drugs. 
These figures may be used to estimate costs: days of 
hospital bed occupancy for drugs represent 40.5% of 
the days of total occupancy for both alcohol and drugs 
and the same percentage of resources allocated for both 
items. Accordingly, we have assumed that 40.5% of the 
resources allocated to alcohol and drugs in hospital care 
corresponds to drugs and 59.5% to alcohol. Since the 
budgets show that total resources allocated to hospital 
treatment for alcohol and drugs was clp 1.062 billion, 
40.5% of that sum, i.e. clp 430.4 million, was spent on 
drug-attributable cases.
In the absence of data on treatment in primary care 
facilities and psychiatric hospitals, we have assumed that 
the resources allocated to alcohol and drugs are distributed 
similarly to the proportions seen in the general hospital 
data. Estimates performed by Olavarría (2009) indicate 
that the costs for both alcohol- and drug-related treatment 
amount to clp 2.195 billion, of which drug-attributable 
treatment would represent 40.5%, or clp 889 million.
In addition, both the estimate for 2003 (conace, 
2005) and the Olavarría study (2009) on alcohol and drugs 
in 2006 include treatment spending by non-governmental 
organizations (ngos); the conace study includes only one 
organization, however, while Olavarría’s work includes 
the amounts spent by nine ngos, all in the Metropolitan 
Region, which responded to the author’s request for 
information. Given that data on ngo treatment spending 
are not compiled systematically, this article has excluded 
them on the basis that a cost study must be based on a 
stable model that can be replicated over time; the random 
selection of these institutions makes it impossible to 
include them in a systematic and comparable study. 
A comprehensive register of ngos working on drug 
rehabilitation with high quality data would be needed 
in order to overcome this problem. 
Conversely, the costs of rehabilitation and 
detoxification treatment in prisons and sename centres are 
well documented and, probably as a result, constitute the 
main item in public health costs. It may be assumed that 
the costs of treatment in private centres are considerable, 
but there is no information in this respect (see table 7).
3. Productivity losses
Costs from productivity losses are often the largest item 
within the estimated socioeconomic costs of drugs. 
In the United States, they represented 71.2% of all 
socioeconomic costs attributed to drug consumption for 
TABLE 5
Hospital stays and hospital bed occupancy 
days due to drugs and alcohol, 2006
Alcohol Drugs
Total stays 7 530 2 447
Total hospital bed occupancy days 69 683 47 441
Average hospital bed occupancy days 9.3 19.4
Percentage of total stays 0.5 0.1
Percentage of total hospital bed 
occupancy days 0.77 0.52
Source: prepared by the author on the basis of data on hospital stays 
from the Department of Health Statistics and Information (deis) of 
the Ministry of Health of Chile.
TABLE 6
Hospital stays and days of hospital bed 
occupancy due to drugs and alcohol as a 
percentage of total for alcohol + drugs, 2006
Drug-related stays as % of stays related to both alcohol 
and drugs
24.5
Alcohol-related stays as % of stays related to both 
alcohol and drugs
75.5
Drug-related hospital bed occupancy as % of occupancy 
related to both alcohol and drugs
40.5
Alcohol-related hospital bed occupancy as % of 
occupancy related to both alcohol and drugs
59.5
Source: prepared by the author on the basis of data on hospital stays 
from the Department of Health Statistics and Information (deis) of 
the Ministry of Health of Chile.
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2002 (Office of National Drug Control Policy, 2004). 
The present cost estimation works initially with two 
categories under this item: (i) costs for disability-adjusted 
life years (dalys) through illness or premature death, 
and the costs for life years lost through imprisonment, 
and (ii) direct and indirect costs. 
(a) Productivity losses from incarceration: direct 
and indirect costs
Costs from incarceration for offences against drug 
laws are obtained from the product of the average number 
of inmates imprisoned for infringements of drug law, 
the minimum monthly wage —clp 131,250 in 2006— 
and a 12-month period. The assumption here is that the 
minimum wage is a more realistic alternative cost5 for 
the adult prison population and the average income for 
the population generally. 
Calculating the costs of imprisonment for crimes 
partly attributable to drugs is rather more difficult. First 
of all, Chile does not record precise information on 
the average number of inmates for each type of crime. 
The only information available is the distribution of 
crimes among the prison population. On the basis of 
that information, a good estimate may be obtained by 
comparing the proportion imprisoned for drug offences. 
Of the average numbers of inmates in closed prisons, 
in 2006 3,468 of a total of 38,007, i.e. 9.13%, were 
5  Olavarría (2009) uses another source and considers only convicted 
inmates. Here the figure for total inmates is used, because those 
charged, on trial and convicted all represent a cost directly associated 
with drug consumption.
imprisoned for drug offences. At the same time, the data 
available on inmates’ crimes shows that of a total of 
139,333 crimes, 12,487, or 8.96%, were drug-related.6 
Since the two percentages are almost identical, for the 
purposes of calculating the average number imprisoned 
each year for drug offences, we assume the percentage 
estimated on the basis of the prison population’s total 
crimes to be equal to the average percentage imprisoned 
for those crimes each year. We always use a 12-month 
period, because the estimate of the average numbers 
imprisoned for each crime is precisely calculated and 
a productivity cost may be assigned for each of the 12 
months. What is not known, however, is the duration of 
imprisonment of each individual by type of crime and 
imprisonment status (detained, on trial or convicted). The 
result of this estimate is shown in the column “average 
prisoners 2006” in table 8. 
Secondly, estimates of productivity losses from 
crimes attributable to use, abuse and traffic of drugs 
which are not, however, typified as offences against 
the drugs law require an estimate of etiologic fractions 
which in Chile has recently been developed by Valenzuela 
and Larroulet (2010). In epidemiology, an etiologic or 
attributable fraction is a form of indirect quantification 
of morbidity and mortality due to a specified risk factor 
(Ridolfo and Stevenson, 2001, p. 2). In this case, the 
fraction corresponds to the proportion of various types 
of crime that may be attributed to the consumption of 
or addiction to different drugs.
6  Crimes and not people: many inmates are in prison for more than 
one crime.
TABLE 7
Public health costs linked to drug consumption and abuse, 2006
(Millions of nominal pesos)
Subitem Millions of pesos
Primary and hospital care Treatment for psychoactive substances in primary health facilities  430
Treatment in general and psychiatric hospitals 889
conace partners fonasa - conace agreement 3 521
conace - genchi agreement  232
Other institutions Contributions from genchi   20
Total 5 093
Source: prepared by the author on the basis of data for 2003 from the National Drug Control Council (conace), Estudio de costos asociados 
al consumo y tráfico de SPA ilegales en Chile para el año 2003, Santiago, Chile, 2005, Olavarría y Asociados, 2009, and data from the 
Department of Health Statistics and Information (deis) of the Ministry of Health of Chile.
conace: National Drug Control Council.
fonasa: National Health Fund.
genchi: Gendarmería (prison guard service) of Chile.
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Valenzuela and Larroulet (2010) use the tripartite 
model by Goldstein (1985) to assess this link. In this 
model, the impact of drug consumption on the commission 
of crime occurs in three scenarios: 
i. A “psycho-pharmacological” connection is said 
to exist where crimes are committed under the 
influence of substances that increase excitability, 
irrationality or disposition to violence, including 
cases in which the victim is under the effects of a 
particular substance, on the understanding that a 
victim’s vulnerability can constitute an opportunity 
to commit a crime.
ii. A “compulsive economic” link is said to exist where 
the drug addict commits a crime in an attempt to 
obtain drugs or the means necessary to obtain them; 
and lastly, 
iii. A “systemic” link exists in those crimes that arise 
from the operation of drug production and exchange 
networks. Based on this conceptualization etiologic 
fractions are estimated for each type of crime and 
connection, on the basis of studies by sename on 
the committing population (sename, 2006) and 
by conace on the adult prison population in 2007 
(conace, 2007). 
Lastly, the minimum wage is used for the income 
factor rather than the average wage, on the basis that 
the minimum wage is a more realistic alternative cost 
in the case of the imprisoned population (see table 8).
(b) Productivity losses from drug-attributable 
morbidity and mortality: disability adjusted 
life years (dalys) 
— Study of disease burden and attributable 
burden in Chile
Losses through morbidity and mortality are a particularly 
important item in international studies. For Chile, the 
Public Health Department of the School of Medicine at 
the Catholic University of Chile (School of Medicine, 
2008) estimated dalys as a “disease burden”, i.e. 
specifically owing to an disease; and dalys as a burden 
attributable to particular behaviours (17 risk factors) in 
other diseases. 
Cause-specific dalys correspond to the sum of years 
lost because of premature death from the specific cause, 
plus years of life lived with disability in cases affected by 
the specific cause. dalys attributable specifically to drug 
addiction provide a gauge of the “direct” effect of drug 
consumption on future health loss. Here the opportunity 
cost of drug-attributable mortality and morbidity is key 
to the resulting estimate.
dalys attributable to drug consumption, as an 
estimate of indirect costs, are obtained from an estimate 
of attributable burden which measures the incidence of 
17 “risk factors” on the final damage (in dalys). The 
attributable burden is the reduction that would be observed 
TABLE 8
Costs in productivity losses from imprisonment: direct costs  












Imprisonment for offences against drugs law (direct cost) 3 468 1 131 250  5 462
Imprisonment for related crime (indirect costs) Theft 14 601 0.327 131 250  7 520
Violent theft 7 906 0.287 131 250  3 574
Sexual crime 1 447 0.079 131 250 180
Homicide 1 939 0.206 131 250 629
Total  17 365
Source: prepared by the author on the basis of: 
a Ministry of Justice, Compendio estadístico de la población atendida por Gendarmería de Chile, Santiago, Chile, Gendarmería de Chile, 
Sub Departamento de Estadística y Control Penitenciario, 2006.
b E. Valenzuela and P. Larroulet, “La relación droga y delito: una estimación de la fracción atribuible”, Estudios públicos, No. 119, Santiago, 
Chile, Centro de Estudios Públicos (cep), 2010.
c Act No. 20.039 on the minimum monthly wage.
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in the actual burden if past levels of exposure had been 
similar to a given hypothetical distribution (School of 
Medicine, 2008, p. 79). The risk factor in this case is 
the use of illicit drugs, which represents by far the least 
significant risk factor of the 17 examined (0.0% of the 
total, School of Medicine, 2008). The study examines 
drug consumption as a risk factor in suicide, violence and 
road traffic accidents, and finds an attributable burden 
of 417 dalys. There are sound reasons to suppose that 
this figure underestimates the burden, mainly because 
it was calculated using the prevalences reported by the 
conace study for the general population. The conace 
study was based on self-reporting,7 which tends to 
underestimate the magnitude of the phenomenon and 
leaves out diseases that do not count as etiologic fractions 
for drugs in Chile, despite having been shown to be 
linked to drug consumption.
The economic burden in terms of productivity losses 
estimated as dalys allows us to attribute a present value 
to potential future income. Since people value current 
benefits more highly than future ones, the discount rate 
applied must significantly influence the amount ultimately 
discounted. Generally speaking, the more uncertain the 
future, the higher the value individuals give to the present 
(Kopp, 2001, p. 19). There is no consensus on the selection 
of a discount rate (Single and others, 2003; Kopp, 2001) 
which, in general, “partly reflects the researcher’s opinion 
about how difficult a society will make it to live as a 
drug user. […] The lower the selected rate, the higher 
the estimated social cost” (Kopp, 2001, p. 19). Usually 
a discount rate of 5% and 10% is suggested, however a 
3% rate is most common (Segel, 2006, p. 30).
The study by the School of Medicine of the Catholic 
University of Chile uses a discount rate of 3%, which it 
states corresponds to the long-term investment growth 
rate and is widely used for evaluating social projects 
(School of Medicine, 2008, p. 33). This is a relatively 
low rate, as a result of which the derived costs may be 
slightly overestimated.
Lastly, the calculation of dalys with respect to 
life expectancy for the different cohorts, rather than 
economically active life, could represent a problem 
for a cost estimate exercise which assigns a value to 
income forgone through failure to produce in working 
life. This difficulty is resolved by including a factor 
for valuation of the time lived at each age (School of 
Medicine, 2008, p. 32), in which a greater weighting is 
given to younger groups.
7  Declaration of an interviewee on whether, for example, he or she 
has consumed drugs in the past 30 days.
— Procedures for estimating drug-attributable 
mortality and morbidity costs (direct and indirect)
The first important decision for estimating costs under 
this item is the amount to be assigned to each daly. Here 
we opt for average income rather than the minimum 
wage, as in productivity losses from imprisonment, 
since the 2006 study on drug consumption in the general 
population in Chile finds that average income reported 
by drug addicts does not differ significantly from that 
reported by the rest of the population (and not only are 
the differences small, but they also favour the addicts). 
Average autonomous daily income is obtained from the 
National Socioeconomic Survey (casen) of 2006. The 
direct costs in productivity losses are obtained from 
the product of drug-addiction-specific dalys, average 
autonomous daily income (clp 11.114 billion in 2006), 
and 365 (days of the year). This calculation indicates that 
Chile’s productivity losses through mortality and morbidity 
directly attributable to drug addiction represented an 
economic burden of clp 103 billion in 2006. 
The same procedure was used for dalys attributed to 
drug-related illnesses other than drug addiction (indirect 
cost). Since dalys attributable to the risk factor of drug 
consumption are underestimated, the amount generated 
by the product of the elements is also underestimated. 
The economic burden of dalys attributable to drug 
consumption as a risk factor for diseases other than 
addiction was clp 1.907 billion at current 2006 prices. 
Overall, the economic burden of mortality and morbidity 
directly and indirectly attributable to illicit drugs appears 
to have been around clp 105 billion (see table 9).
4. Enforcement
Drug-attributable enforcement costs –corresponding to 
the item usually called “law enforcement”– represent 
the highest proportion of estimated costs in this article 
(46.6%). Usually, however, productivity losses represent 
the highest costs (here, 45.1%). There are two main 
reasons for this difference: one is that Chile has very 
solid information for calculating this item (especially 
for adults) and a sound attributable fractions study 
for calculating indirect costs, which has enabled a 
comprehensive estimate. By contrast, the etiologic 
fractions for productivity losses through loss of healthy 
life years (dalys as a risk factor) are underestimated.
Calculation of the cost of enforcement for offences 
directly and indirectly related to drugs usually requires us 
to define a relevant and ideally equivalent activity on the 
basis of which to estimate the proportion of drug-linked 
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activities in an institution’s total activities. This means 
assuming that equal resources are allocated to different 
activities. This assumption is broadly used (Pacula and 
others, 2009, p. 34), but highly implausible: investigation 
of a homicide mobilizes far more resources than a 
petty theft. In order to give each crime a differentiated 
weighting, a proxy was calculated for the relative 
difficulty of investigation of different crimes, based on 
the duration of the judicial processes in each case. As a 
substitute variable, this does not reflect the difficulty of 
investigation exactly or proportionally, since all crimes 
share a threshold level of bureaucratic time and there is 
always greater possibility in some cases of an alternative, 
abbreviated procedure or a more vigorous prosecution. 
A weighting factor is calculated on the basis of a 
standardized average trial duration for each type of crime. 
A factor of less than 1 denotes below-average duration 
(and difficulty) and a factor of higher than one denotes 
the reverse. Table 10 shows the values of the weighting 
factors for crimes in question. 
The crimes studied by Valenzuela and Larroulet 
(2010) are homicide, sexual crimes, violent theft and 
simple theft, which includes all sorts of non-violent 
robbery and petty theft. In order to estimate the relative 
difficulty of simple theft we calculate the weighted average 
(by frequency) for “non-violent robbery” (n=193,517) 
and “petty theft” (n=133,303), which gives 87.16 days, 
or a weighing factor of 0.828.
With this factor incorporated, we calculated the 
costs of enforcement for each institution for crimes 
against the drugs law and related offences. The nominal 
cost of this item exceeded clp 126 billion in 2006, with 
37.3% corresponding to direct costs (prosecution, trial 
and imprisonment for crimes against Act No. 20.000 on 
drugs and narcotics control), and the remaining 62.7% 
corresponding to other types of crimes committed partly 
as a result of drug consumption, abuse or trafficking 
(this last item is less frequent: it refers to crimes, such 
as robbery or homicide, committed in the trafficking of 
drugs). This means that Chile lost over clp 47 billion 
in 2006 in prosecuting drug crimes, and almost clp 
80 billion in enforcement for other types of crime 
attributable to drug consumption and trafficking. The 
police system assumed the largest share of these costs 
(42.6%), followed by the penitentiary system (37.1%) 
and the judicial system (19%). Other smaller institutions 
account for the remaining 1.3% of enforcement costs: 
the Medico-Legal Service, the Financial Analysis Unit, 
the National Customs Service and the Department of 
Maritime Territory and Merchant Navy (directemar)8 
(see table 11).
In turn, 14.7% of these costs (clp 18.541 billion) are 
attributable to the prosecution and custody of juveniles 
for drug offences and other related crimes, while 85.3% 
(clp 107.747 billion) was spent on prosecuting the same 
crimes in the adult population (see table 12).
(a) Direct enforcement costs: adults
For adults, the institutions involved in enforcement 
of drug offences and related crimes are the police, 
Carabineros de Chile, the detective branch, pdi (the 
police system), the courts, the Public Prosecutor’s Office 
and the Public Defender’s Office (judicial system), the 
prison guard service, Gendarmería de Chile (which, 
together with prison-building costs, form the penal 
system), and other smaller institutions. The combined 
economic burden for these institutions of prosecuting 
drug offences was over clp 40 billion in 2006.
— Carabineros de Chile made 448,128 arrests (ine, 
2008b). Of these, 9,870 were for drug offences. 
The relative difficulty weighting for drug offences 
8  Information obtained from the study by Olavarría (2009).
TABLE 9
Direct and indirect costs of productivity losses due to drug-related  
premature morbidity and mortality, 2006
dalysa
Average daily autonomous 
incomeb in pesos
Cost in millions 
of pesos 
dalys attributable to drug addition, specific cause 25 396 11 114 103 022
dalys attributable illicit drug use, attributable burden (risk factor) 470 11 114 1 907
Total 104 929
Source: prepared by the author on the basis of: 
a School of medicine, Estudio de carga de enfermedad y carga atribuible 2007, Santiago, Chile, Department of Public Health, Catholic 
University of Chile, 2008, 
b National Socioeconomic Survey (casen), 2006.
 dalys: disability adjustment life years.
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offences as a proportion of total investigations, 
multiplied by the weighting factor and the 
institutional budget, indicate that pdi spent clp 
5.79 billion on investigating drug crimes in 2006. 
— In 2006 1,013,833 crimes were registered in the Public 
Prosecutor’s Office, of which 11,323 corresponded 
to offences against the drugs law. On the basis of 
the calculation used in the cases above, the Public 
Prosecutor’s Office allocated clp 1.62 billion to 
investigating drug offences in 2006.
— The Public Defender’s Office took in a total of 
212,095 crimes in 2006, of which 8,741 were drug 
offences. Accordingly, this Office spent clp 2.281 
billion on defending cases of drug crime that year.
— The judicial category includes the courts as well as 
the Administrative Corporation of the Judicial Branch 
(capj) and the Judicial Academy. The information 
on crime for the calculation of costs was taken from 
the study by Olavarría (2009) who, in turn, used data 
from an official document prepared by capj; drug 
offences represented 25,764 of a total of 2,193,142 
recorded in the judicial system; the cost associated 
with drug crimes was clp 4.253 billion.
TABLE 10
Duration of trials and relative difficulty estimate (weighting) of crimes, 2006
Time taken (days) Standardized value Weighting factor 
Theft 118 124.2 1.242
Non-violent theft 99 104.2 1.042
Petty theft 70 73.7 0.737
Homicide 297 312.6 3.126
Sexual crimes 234 246.3 2.463
Offences against drugs law 177 186.3 1.863
General average 95 100 1.000
Source: prepared by the author on the basis of information available from the Public Prosecutor’s Office, Boletín estadístico. Año 2006, 
Santiago, Chile, Fiscalía Nacional.
TABLE 11
Enforcement costs, by enforcement system and direct or indirect relation  
with consumption, 2006
(Millions of nominal pesos)
Direct Indirect Total Percentage
Police system 22 155 31 650 53 805 42.6
Judicial system 8 248 15 797 24 045 19.0
Penitentiary and rehabilitation system (sename) 15 035 31 780 46 815 37.1
Others  1 624 - 1 624 1.3
Total 47 062 79 227 126 289 100
(Percentage) (37.3) (62.7) (100)
Source: prepared by the author.
sename: National Children’s Service.
TABLE 12
Enforcement costs, by enforcement 
system and prosecution for trafficking and 
consumption in juveniles and adults, 2006
(Millions of nominal pesos)
Minors Adults Total
Police system 7 427 46 377 53 805
Judicial system 199 23 846 24 045
Penitentiary and rehabilitation 
system (sename)
10 916 35 900 46 815
Others - 1 624 1 624
Total 18 541 107 747 126 288
(Percentage) (14.7) (85.3) (100)
Source: prepared by the author.
sename: National Children’s Service.
is 1.863. The product of the percentage of related 
activities, the weighting factor and the institutional 
budget shows that in 2006 Carabineros de Chile 
spent clp 13.169 billion on prosecuting drug crimes.
— The detective branch, pdi conducted a total of 179,955 
investigations in 2006, of which 6,468 related to 
drugs (ine, 2008a, p. 101). Investigations of drug 
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— Gendarmería de Chile registered an average of 
3,468 individuals imprisoned for drug offences in 
2006 against a total of 38,007 on average that year. 
This corresponded to 9.13% of crimes committed 
by prisoners; this percentage is also assumed to 
apply to the proportion of resources used for drug-
related imprisonment (no weighting factor is used 
here, since the effort and resources expended by 
the prison guard service do not vary by type of 
crime). Accordingly, in 2006 Gendarmería spent 
clp 11.152 billion on drug-related imprisonment.
— The cost of prison-building must be added to the 
previous calculations. According to the study by 
Olavarría (2009), the annual cost of prison-building 
should be measured by yearly depreciation. Olavarría 
assumes prisons to have a useful life of 50 years, 
so that prison-building costs for 2006 would be a 
fiftieth of the cost updated to 2006 of building the 
prisons in operation that year (Olavarría, 2009, 
p. 65). By multiplying annual depreciation by 
the proportion of inmates imprisoned for drug 
offences, it is found that Chile spent clp 349 
million on prison-building for incarcerating drug 
offenders. This figure does not coincide with that 
presented in the Olavarría study, because it counts 
both drug- and alcohol-related crimes and only 
prisoners who have been convicted, whereas the 
present study includes those convicted, on trial 
or charged for drug (but not alcohol) crime, since 
they are all held in facilities run by Gendarmería. 
As always, the estimates correspond to the annual 
average number of inmates per crime, not the total 
number of individuals for whom Gendarmería is 
responsible.
— The drug-attributable costs carried by the Medico-
Legal Service are estimated as spending represented 
on toxicology tests as a percentage of total laboratory 
tests (15%), which in turn represent 61% of the 
expenditure incurred by the Service. On this basis, 
the institution spent clp 989 million on drug tests 
in 2006.
— With regard to the Financial Analysis Unit of the 
Ministry of Finance, which investigates monetary 
laundering, there is no information on the percentage 
of suspicious transaction reports which are drug-
related. It was therefore assumed the distribution is 
similar to that in the Public Prosecutor’s Office, which 
gives an annual expenditure of clp 132 million on 
investigating drug-related money laundering crime.
— The National Customs Service spent clp 344 
million on drug-related enforcement in 2006; this 
figure comes from the budget of the Service’s Drugs 
Control Department.
— The Department of Maritime Territory and Merchant 
Navy (directemar) engages in a range of activities 
to investigate and combat drug trafficking; according 
to the information provided to Olavarría (2009), 
these represent 0.48% of the institution’s total 
activities. On this basis, the Department spent clp 
157 million on this item in 2006 (see table 13).
(b) Direct enforcement costs: juveniles
With regard to juveniles, or under-age offenders, it 
is estimated that in 2006 Carabineros de Chile, the courts 
and the National Children’s Service (sename) together 
spent clp 6.822 billion on drug crime enforcement. 
However, the information for juveniles is imprecise, 
since before the juvenile penal responsibility act came 
into effect there were no proper information systems 
exclusively for under-age offenders.
— There is no precise information on the number 
of under-age offenders detained for drug-related 
offences in 2006; however, Carabineros de Chile 
is known to have detained 25,952 juveniles that 
year and information is also known on the profiles 
of law-breaking minors entering the “24 hours 
programme”9 between 2001 and 2005. In order 
to estimate the number of crimes in 2006, it was 
assumed that detainments were distributed by crime 
in the same manner as in 2001-2005. It was thus 
deduced that 2,396 juveniles were detained in 2006 
for drug consumption (the only drug-related crime 
which is categorized), which represents 0.53% of all 
detentions that year. After incorporating the weighting 
factor, we calculate that the Carabineros de Chile 
spent clp 3.196 billion on detaining juveniles for 
drug consumption in 2006 (see table 14). 
— There is a large information gap with respect 
to juvenile offenders before the juvenile penal 
responsibility act came into effect in 2007. There 
are no public prosecution records for minors aged 
14-17 declared competent to stand trial, because in 
that case they were tried as adults. Nor is there any 
information on the defence side. It is therefore not 
possible to estimate the costs for these institutions 
and only a very rough estimate can be ventured for 
9   Formally known as the 24-hour integrated safety programme 
for children and adolescents, the scheme’s objective is to compile 
information on children and teenagers entering the police system and 
to connect them with the social protection and care network organized 
around municipalities with the objective of early crime prevention 
(Allende and Valenzuela, 2008).
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TABLE 13
Enforcement costs directly attributable to drug trafficking  
and consumption, adults, 2006




















Carabineros 320 931 9 870 448 128 1.863 4.10 13 169
pdi 86 469 6 468 179 955 1.863 6.70 5 790
Judicial 
system
Public Prosecutor’s Office 77 878 11 323 1 013 883 1.863 2.08 1 620
Public Defender’s Office 29 719 8 741 212 095 1.863 7.68 2 282
Courts 194 337 25 764 2 193 142 1.863 2.19 4 253
Penal system genchi 122 152 12 726 139 333 - 9.13 11 152
Prison-buildingc 3 825 3 468 38 007 - 9.13 349
Others mls 22 757 - 989
fau 745 - 17.86 133
Customs - 345
directemar 36 440 16 686 3 878 160 - 0.48 157
Total 40 239
Source: prepared by the author on the basis of data from: a M. Olavarría, Estudio nacional sobre costos humanos, sociales y económicos de 
las drogas en Chile, 2006, Santiago de Chile, Olavarría y Asociados, 2009; Olavarría (2009); b National Statistical Institute (ine), Anuario 
de estadísticas policiales. Policía de Investigaciones de Chile, Santiago, Chile, 2008; and Carabineros. Informe anual 2006, Santiago, Chile, 
2008; ine (2008a y 2008b Public Prosecutor’s Office, Boletín estadístico. Año 2006, Santiago, Chile, Fiscalía Nacional.); Public Prosecutor’s 
Office (undated); Public Defender’s Office, Informe estadístico. Año 2006, Santiago, Chile; Public Defender’s Office (undated); Poder Judicial, 
Memoria anual 2006, Santiago, Chile, (2007); Ministry of Justice, Compendio estadístico de la población atendida por Gendarmería de 
Chile, Santiago, Chile, Gendarmería de Chile, Sub Departamento de Estadística y Control Penitenciario, 2006; c Annual depreciation.
fau: Financial Analysis Unit.
mls: Medico-Legal Service.
directemar: Department of Maritime Territory and Merchant Navy.
TABLE 14
Enforcement costs directly attributable to drug trafficking  
and consumption, juveniles, 2006


















Police system Police (Carabineros) 320 931 2 396 448 128 1.863 0.53 3 196
Judicial system Judicial branch 194 337 563 2 193 142 1.863 0.03 93
sename 53 042 368 5 524 1 6.66 3 534
Total 6 823
Source: prepared by the author on the basis of information from: 
sename: National Children’s Service.
a M. Olavarría, Estudio nacional sobre costos humanos, sociales y económicos de las drogas en Chile, 2006, Santiago, Chile, Olavarría y 
Asociados, 2009; National Children’s Service (sename), Informe final de evaluación. Programa de Administración Directa, Santiago, Chile, 
2007; Olavarría (2009); sename (2007); informal communications from sename staff; 
b National Institute of Statistics (ine), Carabineros. Informe anual 2006, Santiago, Chile, 2008;ine (2008b Carabineros de Chile/Government 
of Chile (2007), Programa de Seguridad Integrada para Niños, Niñas y Adolescentes “24 Horas”, Santiago, Chile).
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the court system. Since the number of drug crimes 
(indeed all crimes) entered in 2006 is not known, an 
estimate is performed on the basis of trials citing a 
specific offence as a proportion of completed trials 
(crimes are not specified for unfinished trials). This 
gives a drastic underestimation of the resources 
allocated to judicial procedures, since it yields the 
conclusion that 503 juveniles entered the courts for 
drug offence in 2006, which —including the difficulty 
estimator— would means that only 0.03% of the 
institution’s resources, i.e. clp 93 million per year, 
were spent on investigating juvenile drug crime. 
This underestimated figure is, however, offset by 
the magnitude of resources allocated by sename, 
a non-punitive —in principle—institution which 
also reports to the Ministry of Justice.
— With regard to crime, the role of sename consists 
more of rehabilitation than punishment. However, 
the Service is responsible for detaining or monitoring 
juvenile offenders who are imprisoned full or part 
time. Difficulties surround the estimation of costs 
for sename, too, since although the information on 
the juveniles in its care is public, reliable budgetary 
information is lacking for juvenile offenders, since 
there was no institutional division to this effect before 
the juvenile penal responsibility act. The budget 
information used is a reconstruction of different 
pieces of information provided by sename officials 
and the information submitted by sename for the 
final report on the direct administration programme 
(sename, 2007). On this basis, we estimate that in 
2006 sename spent clp 3.534 billion on juveniles 
who committed drug-related crimes (see table 14).
(c) Indirect enforcement costs: adults
As noted earlier, one of the soundest aspects of 
this article is the estimate of indirect costs of drug 
enforcement based on the recent paper on attributable 
fractions by Valenzuela and Larroulet (2010) and on 
detailed information on drug-related crime from the 
various institutions involved.
As may be surmised from table 15, in 2006 the 
main institutions involved in prosecuting crime in 
Chile spent clp 67.508 billion on enforcement for 
crimes committed by individuals over age 18 because 
of drugs, whether to obtain it (in the case of addicts), 
under its influence (when the crime would not have been 
committed otherwise) or in the drug market, following 
Goldstein’s tripartite model.
The institutions spending the most on related crimes 
were Gendarmería (clp 23.658 billion) and Carabineros 
de Chile (clp 17.194 billion). They are followed by pdi 
(clp 10.225 billion) and the Public Prosecutor’s Office 
(clp 9.403 billion). If these amounts are broken down 
by crime, simple theft is by far the most common crime 
committed because of drugs. It costs the institutions 
involved clp 47.841 billion, i.e. 71% of costs for drug-
related crime. Following at a considerable distance are 
violent theft (clp 16.184 billion), sexual crime (clp 2.142 
billion) and homicide (clp 1.341 billion).
TABLE 15
Enforcement costs indirectly attributable to drug trafficking and consumption, 
adults, by type of crime, 2006
(Millions of nominal pesos)
Simple theft Violent theft Sexual crimes Homicides Total
Judicial system Public Prosecutor’s Office 6 874 2 276 227 26 9 403
Public Defender’s Office 1 859 731 87 59 2 736
Courts 2 414 949 113 77 3 552
Police system Carabineros 14 637 2 353 120 83 17 194
pdi 6 239 2 354 1 217 416 10 225
Penal system Gendarmería 15 338 7 292 367 660 23 658
Prison-building 480 228 12 21 741
Total 47 841 16 184 2 142 1 341 67 508
Source: prepared by the author on the basis of information from M. Olavarría, Estudio nacional sobre costos humanos, sociales y económicos 
de las drogas en Chile, 2006, Santiago, Chile, Olavarría y Asociados, 2009; National Institute of Statistics (ine), Anuario de estadísticas 
policiales. Policía de Investigaciones de Chile, Santiago, Chile, 2008; and Carabineros. Informe anual 2006, Santiago, Chile, 2008; Public 
Prosecutor’s Office, Boletín estadístico. Año 2006, Santiago, Chile, Fiscalía Nacional.); Public Defender’s Office, Informe estadístico. Año 
2006, Santiago, Chile; Poder Judicial, Memoria anual 2006, Santiago, Chile, 2007; Public Prosecutor’s Office, Compendio estadístico de 
la población atendida por Gendarmería de Chile, Santiago, Chile, Gendarmería de Chile, Sub Departamento de Estadística y Control 
Penitenciario, 2006; and E. Valenzuela y P. Larroulet, “La relación droga y delito: una estimación de la fracción atribuible”, Estudios 
públicos, N° 119, Santiago, Chile, Centro de Estudios Públicos, 2010.
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The calculation is the same as that used for the 
section on direct costs, except that in this case it includes 
attributable fractions. 
(d) Indirect enforcement costs: juveniles
The estimation of indirect costs for juveniles uses 
the same strategies as those described for estimating the 
direct costs for this group, owing to gaps in the information 
available. Again, therefore, the cost of justice is heavily 
underestimated. The calculation applies an attributable 
fraction factor for each crime, which is specific to the 
juvenile population (Valenzuela and Larroulet, 2010).
Together, the institutions involved spent clp 11.719 
billion on enforcement for drug-related crimes. The 
institution with the heaviest costs in this area was sename, 
with clp 7.382 billion, followed by Carabineros de Chile, 
with clp 4.231 billion and the judicial system with clp 
106 million, though this is a drastic underestimate. 
By crime, simple theft is again the crime that 
imposes the highest costs on the enforcement system 
(clp 6.362 billion, or 54%), although the lead is far 
shorter than is the case with adults. This is followed 
quite closely by drug-related theft with violence and 
intimidation (clp 5.245 billion, or 45%), and at a greater 
distance by homicide (clp 73 million) and sexual crime 
(clp 38 million), which are statistically insignificant 
in this population (a combined 1% between the two) 
(see table 16). 
TABLE 16
Enforcement costs indirectly attributable to drug trafficking  
and consumption, juveniles, 2006
















Judicial system Courts 44 62 0.378 0.165 106
Police system Carabineros 1 952 2 279 - - 4 231
sename 4 366 2 904 38 73 7 382
Total 6 362 5 245 38 73 11 719
Source: prepared by the author on the basis of information from Poder Judicial, Memoria anual 2006, Santiago, Chile, 2007; Carabineros 
de Chile/Government of Chile (2007), Programa de Seguridad Integrada para Niños, Niñas y Adolescentes “24 Horas”, Santiago, Chile; 




This article has attempted to demonstrate that the economic 
burden of drug consumption and trafficking in Chile in 
2006 was at least clp 266.744 billion in current prices 
that year, or clp 207.531 billion in today’s terms (30 
April 2011). Much of that sum reflects productivity losses 
and enforcement costs, be it for drug offences directly 
or other crimes committed because of drugs. The losses 
directly attributable to drug consumption and trafficking 
are estimated at clp 173.708 billion, and the indirect 
costs are estimated at clp 93.036 billion (see table 17).
These results were obtained using the coi approach 
to evaluate the impacts of drug consumption and 
trafficking on society as a whole. This indictor of “negative 
TABLE 17
total costs by item, direct and indirect, 2006
(Millions of nominal pesos)
Direct Indirect Total
Prevention 13 070 13 070
Public health 5 093 5 093
Productivity losses 108 484 13 810 122 293
Enforcement (adults  
and juveniles) 47 062 79 227 126 288
Total 173 708 93 036 266 744
Total adjusted to 30 
April 2011 207 531 111 151 318 681
Source: prepared by the author. 
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externality” may serve as a basis for decision-making 
and for gauging the effectiveness of programmes and 
public policies aimed at reducing drug consumption and 
trafficking and its harmful effects on society at large. A 
study of this sort also brings to light information which 
is not usually available to researchers and the general 
public, either because it is not published or because 
the various institutions categorize it in different ways.
The estimates given have failings which have been 
amply described. Insofar as they reflect information gaps, 
they highlight the need for specific studies in Chile to 
produce more accurate estimates that can quantify the 
problem more realistically. The main requirements in 
this regard are as follows:
(i) Ideally, all State institutions should provide accurate 
and detailed information. This is particularly 
urgent in the case of the public health system, the 
judicial system and the prison guard service. The 
public health system should separate drug- and 
alcohol-related items in their reported budgets and 
make budgetary information available not only in 
reference to hospital care, but also for primary 
care, especially as regards the cost of treating drug-
related diseases other than addiction. It would also 
be desirable to produce unified records for care 
and treatment in the private health system, in order 
to quantify the treatment given for addiction and 
other drug-related illnesses. The judicial system 
should provide more detailed information on its 
actions and respective budget, and Gendarmería 
should produce a clear record of crimes by judicial 
status, and a reliable profile of the individuals 
imprisoned by type of crime.
(ii) A comprehensive register of ngos involved in work 
on illicit drugs in Chile would be highly useful, 
distinguishing autonomous budget fractions from 
government contributions.
(iii) Chile should encourage the development of 
attributable fractions studies to help determine the 
degree of relation between drug consumption and 
related behaviours or consequences, especially in the 
field of health. Work in Australia, Canada and the 
United States has shown that such studies provide 
extremely valuable information for public policy 
interventions, with a view to targeting interventions 
and resources on substances that generate the most 
adverse impacts in aggregate terms.
(iv) More generally, Chile needs studies of this sort 
with unified criteria in order to evaluate the costs 
of tobacco and alcohol consumption, in order 
to compare their consequences and target and 
integrate interventions. A unified methodology, as 
in Australia and Canada, would enable comparison 
of the harmful effects of each substance and 
provide grounds for decisions on channelling 
prevention and rehabilitation resources. Although 
government agencies responsible for illegal drug 
matters afford great importance to drug consumption 
and its potential effects, these studies offer a means 
of assessing the burden that each drug represents 
for society in a more objective, substantiated 
manner. There is no reason, a priori, to assume 
that illegal drug prevention and rehabilitation merit 
more attention than legal drugs. It is possible that 
in Chile, for example, just as programmes tackle 
illegal drugs such as cocaine base paste, they should 
more broadly tackle alcohol, which is taxed less 
than tobacco and is allowed to be advertised, despite 
the fact that alcohol both directly and indirectly 
generates multiple forms of violence and a higher 
cost in dalys than tobacco.
The steps suggested would enable Chile to develop 
high-quality instruments for measuring the scale of 
problems associated with drug consumption and trafficking 
and for setting a solid baseline to support analysis of 
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